NM_000059.3(BRCA2):c.3195_3198delTAAT (p.Asn1066Leufs) AND Breast-ovarian cancer, familial 2
- Germline classification:
- Pathogenic (2 submissions)
- Last evaluated:
- Feb 20, 2004
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000113145.2
Allele description
NM_000059.3(BRCA2):c.3195_3198delTAAT (p.Asn1066Leufs)
Condition(s)
- Name:
- Breast-ovarian cancer, familial 2 (BROVCA2)
- Synonyms:
- BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; Breast cancer, familial 2
- Identifiers:
- MedGen: C2675520; Orphanet: 145; OMIM: 612555
- Age of onset:
- All ages
- Prevalence:
- 1-9 / 100 000 Orphanet: 145
- Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity. http://www.ncbi.nlm.nih.gov/books/NBK1247
Assertion and evidence details
Last Updated: Aug 29, 2016